CAJ | 학술논문

目的：探讨GPH基因技术在治疗非淋等泌尿生殖感染中的临床效果。方法选择2012年8月~2013年10月哈尔滨市223例性病就诊者进行治疗，其中非淋菌性尿道炎91例，淋病64例,尖锐湿疣38列，生殖器疱疹，24例，软下疳6例，均有非婚性接触史。结果经过长达4～6个月的跟踪随访，治愈率为98.21%。结论GPH基因技术在治疗非淋等泌尿生殖感染方面取得了显著效果，充分显示出GPH基因技术所具有的疗效显著、治疗安全、不易复发的突出优势。
목적：탐토GPH기인기술재치료비림등비뇨생식감염중적림상효과。방법선택2012년8월~2013년10월합이빈시223례성병취진자진행치료，기중비림균성뇨도염91례，임병64례,첨예습우38렬，생식기포진，24례，연하감6례，균유비혼성접촉사。결과경과장체4～6개월적근종수방，치유솔위98.21%。결론GPH기인기술재치료비림등비뇨생식감염방면취득료현저효과，충분현시출GPH기인기술소구유적료효현저、치료안전、불역복발적돌출우세。
Objective To explore the clinical effect of GPH gene technology in the treatment of urogenital infections such as non-gonococcal urethritis. Methods 223 patients with sexually transmitted diseases who were treated in Harbin from August 2012 to October 2013 were selected, among whom 91 patients were diagnosed as non-gonococcal urethritis,64 gonorrhea,38 condyloma acuminatum,24 genital herpes and 6 chancroid.They all had unmarried sexual contact. Results The recovery rate was 98.21% during follow-ups up to 4-6 months. Conclusion The GPH gene technology achieves significant effect in the treatment of urogenital infections such as non-gonococcal urethritis,which proves its outstanding advantages of significant curative effect,safe treatment and being uneasy to relapse.